Search | IOVS | ARVO Journals

Showing 1 – 20 of 66

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Aflibercept (Eylea) inhibits dendritic cell migration

Matthias Hamdorf; Jasmin Weindler; Ann-Charlott Salabaria; Claus Cursiefen; Felix Bock

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):907 – A0271. doi:

ARVO Annual Meeting Abstract June 2022

Pilot Data on Safety and Efficacy of Combined Corneal Crosslinking and Fine Needle Diathermy for Regression of Pathological Corneal Neovascularization and Corneal Stabilization Prior to High-Risk Keratoplasty

Mert Mestanoglu; Heide Heinen; Friederike Schaub; Felix Bock; Deniz Hos; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):906 – A0270. doi:

ARVO Annual Meeting Abstract June 2022

Strain dependent influence of UVA-based corneal crosslinking (CXL) on corneal immune cell populations

Shuya Deng; Wei Zhang; Alfrun Patricia Schönberg; Felix Bock; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):905 – A0269. doi:

ARVO Annual Meeting Abstract June 2022

Injury dependent immune cell recruitment into the cornea

Felix Bock; Wei Zhang; Alfrun Patricia Schönberg; Fiona Bassett; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):903 – A0267. doi:

ARVO Annual Meeting Abstract June 2022

Corneal crosslinking ameliorates degree of corneal edema in subsequent acute keratoconus

Claus Cursiefen; Wei Zhang; yanhong hou; shuja deng; Antonia Howaldt; Felix Bock

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2409 – A0212. doi:

ARVO Annual Meeting Abstract June 2022

The transcription factor NFAT5 is a crucial regulator of corneal edema resolution after injury

Karina Hadrian; Gwen Musial; Alfrun Patricia Schönberg; Tihomir Georgiev; Felix Bock; Sabine Anne Eming; Claus Cursiefen; Deniz Hos

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3625 – A0190. doi:

ARVO Annual Meeting Abstract June 2022

Posttransplant VEGFR1R2 Trap eye drops improve corneal high-risk allograft survival

Wei Zhang; Alfrun Patricia Schönberg; Felix Bock; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):910 – A0274. doi:

ARVO Annual Meeting Abstract June 2022

Effect of sCD83 on direct allosensitization after corneal transplantation

Alfrun Patricia Schönberg; Katrin Peckert-Maier; Karina Hadrian; Matthias Hamdorf; Claus Cursiefen; Elisabeth Zinser; Felix Bock

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):417. doi:

Articles May 2022

Posttransplant VEGFR1R2 Trap Eye Drops Inhibit Corneal (Lymph)angiogenesis and Improve Corneal Allograft Survival in Eyes at High Risk of Rejection

PDF

Wei Zhang; Alfrun Schönberg; Felix Bock; Claus Cursiefen
TAGS: cd40 ligand, cornea, eye, eyedrops, keratoplasty, rejection (psychology), telomeric repeat amplification protocol, thyroid hormone associated protein complex, allografting, transplantation
Trans. Vis. Sci. Tech.. 2022; 11(5):6. doi: https://doi.org/10.1167/tvst.11.5.6

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Descemet Membrane Endothelial Keratoplasty (DMEK) in vascularized high-risk eyes

Takahiko Hayashi; Wei Zhang; Deniz Hos; Silvia Schrittenlocher; Viet Nhat Hung Le; Sebastian Siebelmann; Mario Matthaei; Björn Bachmann; Felix Bock; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):985. doi:

ARVO Annual Meeting Abstract June 2021

Corneal Crosslinking to Regress Pathological Corneal Neovascularization Before High-Risk Keratoplasty

Deniz Hos; Friederike Schaub; Yanhong Hou; Wei Zhang; Felix Bock; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):974. doi:

ARVO Annual Meeting Abstract June 2021

Basement membrane integrity maintains blood vessel networks in inflamed corneas

Felix Bock; Viet Nhat Hung Le; Manuel Koch; Raphael Reuten

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):929. doi:

ARVO Annual Meeting Abstract June 2021

Effect of sCD83 on macrophages in corneal high-risk transplantation

Alfrun Schönberg; Katrin Peckert-Maier; Andreas Wild; Dmytro Royzman; Gabriele Braun; Lena Stich; Claus Cursiefen; Alexander Steinkasserer; Felix Bock; Elisabeth Zinser

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):909. doi:

ARVO Annual Meeting Abstract June 2021

Aflibercept influences the immunocompetence of Dendritic Cells.

Jasmin J Weindler; Felix Bock; Matthias Hamdorf; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):900. doi:

ARVO Annual Meeting Abstract June 2021

Cystathionine β-synthase as novel regulator of lymphangiogenesis

Niloofar Hatami; Christian Büttner; Felix Bock; Sara Simfors; André Reis; Claus Cursiefen; Thomas Clahsen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):899. doi:

ARVO Annual Meeting Abstract June 2021

Injury dependent angiogenic responses in the cornea

Wei Zhang; Karina Hadrian; Claus Cursiefen; Felix Bock

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):897. doi:

Articles October 2020

VEGF Trap R1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis

PDF

Viet Nhat Hung Le; Deniz Hos; Yanhong Hou; Madlen Witt; Mikhail Barkovskiy; Felix Bock; Claus Cursiefen
TAGS: aflibercept, cornea, corneal neovascularization, lymphangiogenesis, alkanes, cd40 ligand, thyroid hormone associated protein complex
Trans. Vis. Sci. Tech.. 2020; 9(11):15. doi: https://doi.org/10.1167/tvst.9.11.15

ARVO Annual Meeting Abstract July 2019

Local VEGF-A blockade modulates the microenvironment of corneal transplantion side

Felix Bock; Ann-Charlott Schneider; Claus Cursiefen; Manuel Koch; Raphael Reuten; Esther Mahabir; Gabriele Braun; Malte Heykants

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):895. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of UV-light crosslinking and Fine needle-diathermy to regress pathological corneal lymphatic and blood vessels in vivo

Yanhong Hou; Viet Nhat Hung Le; Felix Bock; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):941. doi:

ARVO Annual Meeting Abstract July 2019

Tyrosinase is a novel endogenous inhibitor of lymphangiogenesis

Thomas Clahsen; Christian Büttner; Birgit Regenfuss; Tim Gabriel; Felix Bock; André Reis; Claus Cursiefen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):942. doi:

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Aflibercept (Eylea) inhibits dendritic cell migration

Pilot Data on Safety and Efficacy of Combined Corneal Crosslinking and Fine Needle Diathermy for Regression of Pathological Corneal Neovascularization and Corneal Stabilization Prior to High-Risk Keratoplasty

Strain dependent influence of UVA-based corneal crosslinking (CXL) on corneal immune cell populations

Injury dependent immune cell recruitment into the cornea

Corneal crosslinking ameliorates degree of corneal edema in subsequent acute keratoconus

The transcription factor NFAT5 is a crucial regulator of corneal edema resolution after injury

Posttransplant VEGFR1R2 Trap eye drops improve corneal high-risk allograft survival

Effect of sCD83 on direct allosensitization after corneal transplantation

Posttransplant VEGFR1R2 Trap Eye Drops Inhibit Corneal (Lymph)angiogenesis and Improve Corneal Allograft Survival in Eyes at High Risk of Rejection

Descemet Membrane Endothelial Keratoplasty (DMEK) in vascularized high-risk eyes

Corneal Crosslinking to Regress Pathological Corneal Neovascularization Before High-Risk Keratoplasty

Basement membrane integrity maintains blood vessel networks in inflamed corneas

Effect of sCD83 on macrophages in corneal high-risk transplantation

Aflibercept influences the immunocompetence of Dendritic Cells.

Cystathionine β-synthase as novel regulator of lymphangiogenesis

Injury dependent angiogenic responses in the cornea

VEGF Trap R1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis

Local VEGF-A blockade modulates the microenvironment of corneal transplantion side

Comparison of UV-light crosslinking and Fine needle-diathermy to regress pathological corneal lymphatic and blood vessels in vivo

Tyrosinase is a novel endogenous inhibitor of lymphangiogenesis

To View More...

You must be signed into an individual account to use this feature.